CliffBio
small molecule

NITROLINGUAL PUMPSPRAY

NITROGLYCERIN

Loss of exclusivityMarch 2029latest FDA-listed patent expiry
CompanyPOHL BOSKAMP

Drug detail

Brand nameNITROLINGUAL PUMPSPRAY
Active ingredientNITROGLYCERIN
Strength0.4MG/SPRAY
Dosage formSPRAY, METERED
RouteSUBLINGUAL
ModalitySmall molecule
FDA approvalJanuary 1997
Marketing statusRX

Listed patents

PatentExpiresType
7872049March 2029product

More from POHL BOSKAMP

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

NITROLINGUAL PUMPSPRAY patent cliff — loss of exclusivity March 2029 | CliffBio